Financial toxicity among cancer patients, survivors and their families in the United Kingdom: a scoping review

Tran T Ngan; Tran H Tien; Michael Donnelly; Ciaran O'Neill

doi:10.1093/pubmed/fdad143

Financial toxicity among cancer patients, survivors and their families in the United Kingdom: a scoping review

Tran T Ngan^*
, Tran H Tien
, Michael Donnelly
, Ciaran O'Neill

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

31 Citations (Scopus)

136 Downloads (Pure)

Abstract

Background
The aim of this scoping review was to identify key research gaps and priorities in order to advance policy and practice for people living with cancer in the UK.

Methods
The review adhered to PRISMA guidelines for scoping review. We searched MEDLINE, EMBASE, Scopus, Web of Science and Google Scholar on 16 July 2022. There were no restrictions in terms of study design and publication time; gray literature was included. The key words, ‘financial’ or ‘economic’, were combined with each of the following words ‘hardship/stress/burden/distress/strain/toxicity/catastrophe/consequence/impact.’

Results
29/629 studies/reports published during 1982–2022 were eligible to be included in the review. No study conducted a comprehensive inquiry and reported all aspects of financial toxicity (FT) or used a validated measure of FT. The most three commonly reported outcomes related to financial hardship were financial well-being (24/29), benefit/welfare (17/29) and mental health status (16/29).

Conclusions
It is evident that FT is experienced by UK cancer patients/survivors and that the issue is under-researched. There is an urgent need for further research including rigorous studies which contribute to a comprehensive understanding about the nature and extent of FT, disparities in experience, the impacts of FT on outcomes and potential solutions to alleviate FT and related problems.

Original language	English
Pages (from-to)	e702-e713
Number of pages	12
Journal	Journal of Public Health
Volume	45
Issue number	4
Early online date	04 Aug 2023
DOIs	https://doi.org/10.1093/pubmed/fdad143
Publication status	Published - Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Financial Toxicity
Cancer
United Kingdom (UK)
Health economics

Access to Document

10.1093/pubmed/fdad143Licence: CC BY

Financial toxicity among cancer patients, survivors and their families in the United Kingdom: a scoping review
Copyright 2023 The Authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
Final published version, 976 KBLicence: CC BY

1 Active

R2026CPH: Understanding causes & impacts of financial toxicity among cancer patients, survivors, and their family in the United Kingdom (GIFT)
Tran, N. (PI), Donnelly, M. (CoI) & O'Neill, C. (CoI)
07/06/2023 → …
Project: Research

Wellcome Early-Career Award
Tran, N. (Recipient), 01 Aug 2023
Prize: Fellowship awarded competitively

31 Citations
1 Article

Financial toxicity amongst cancer patients and survivors: a comparative study of the United Kingdom and United States
Ngan, T. T., Tonorezos, E., Donnelly, M. & O’Neill, C., Jun 2025, In: Supportive Care in Cancer. 33, 6, 521.
Research output: Contribution to journal › Article › peer-review

Open Access
File
12 Link opens in a new tab Citations (Scopus)

71 Downloads (Pure)

Cite this

@article{79d5b2aa35d64cae8590011c230f5b57,

title = "Financial toxicity among cancer patients, survivors and their families in the United Kingdom: a scoping review",

abstract = "Background The aim of this scoping review was to identify key research gaps and priorities in order to advance policy and practice for people living with cancer in the UK. Methods The review adhered to PRISMA guidelines for scoping review. We searched MEDLINE, EMBASE, Scopus, Web of Science and Google Scholar on 16 July 2022. There were no restrictions in terms of study design and publication time; gray literature was included. The key words, {\textquoteleft}financial{\textquoteright} or {\textquoteleft}economic{\textquoteright}, were combined with each of the following words {\textquoteleft}hardship/stress/burden/distress/strain/toxicity/catastrophe/consequence/impact.{\textquoteright} Results 29/629 studies/reports published during 1982{\textendash}2022 were eligible to be included in the review. No study conducted a comprehensive inquiry and reported all aspects of financial toxicity (FT) or used a validated measure of FT. The most three commonly reported outcomes related to financial hardship were financial well-being (24/29), benefit/welfare (17/29) and mental health status (16/29). Conclusions It is evident that FT is experienced by UK cancer patients/survivors and that the issue is under-researched. There is an urgent need for further research including rigorous studies which contribute to a comprehensive understanding about the nature and extent of FT, disparities in experience, the impacts of FT on outcomes and potential solutions to alleviate FT and related problems. ",

keywords = "Financial Toxicity, Cancer, United Kingdom (UK), Health economics",

author = "Ngan, \{Tran T\} and Tien, \{Tran H\} and Michael Donnelly and Ciaran O'Neill",

year = "2023",

month = dec,

doi = "10.1093/pubmed/fdad143",

language = "English",

volume = "45",

pages = "e702--e713",

journal = "Journal of Public Health",

issn = "1741-3850",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Financial toxicity among cancer patients, survivors and their families in the United Kingdom: a scoping review

AU - Ngan, Tran T

AU - Tien, Tran H

AU - Donnelly, Michael

AU - O'Neill, Ciaran

PY - 2023/12

Y1 - 2023/12

N2 - Background The aim of this scoping review was to identify key research gaps and priorities in order to advance policy and practice for people living with cancer in the UK. Methods The review adhered to PRISMA guidelines for scoping review. We searched MEDLINE, EMBASE, Scopus, Web of Science and Google Scholar on 16 July 2022. There were no restrictions in terms of study design and publication time; gray literature was included. The key words, ‘financial’ or ‘economic’, were combined with each of the following words ‘hardship/stress/burden/distress/strain/toxicity/catastrophe/consequence/impact.’ Results 29/629 studies/reports published during 1982–2022 were eligible to be included in the review. No study conducted a comprehensive inquiry and reported all aspects of financial toxicity (FT) or used a validated measure of FT. The most three commonly reported outcomes related to financial hardship were financial well-being (24/29), benefit/welfare (17/29) and mental health status (16/29). Conclusions It is evident that FT is experienced by UK cancer patients/survivors and that the issue is under-researched. There is an urgent need for further research including rigorous studies which contribute to a comprehensive understanding about the nature and extent of FT, disparities in experience, the impacts of FT on outcomes and potential solutions to alleviate FT and related problems.

AB - Background The aim of this scoping review was to identify key research gaps and priorities in order to advance policy and practice for people living with cancer in the UK. Methods The review adhered to PRISMA guidelines for scoping review. We searched MEDLINE, EMBASE, Scopus, Web of Science and Google Scholar on 16 July 2022. There were no restrictions in terms of study design and publication time; gray literature was included. The key words, ‘financial’ or ‘economic’, were combined with each of the following words ‘hardship/stress/burden/distress/strain/toxicity/catastrophe/consequence/impact.’ Results 29/629 studies/reports published during 1982–2022 were eligible to be included in the review. No study conducted a comprehensive inquiry and reported all aspects of financial toxicity (FT) or used a validated measure of FT. The most three commonly reported outcomes related to financial hardship were financial well-being (24/29), benefit/welfare (17/29) and mental health status (16/29). Conclusions It is evident that FT is experienced by UK cancer patients/survivors and that the issue is under-researched. There is an urgent need for further research including rigorous studies which contribute to a comprehensive understanding about the nature and extent of FT, disparities in experience, the impacts of FT on outcomes and potential solutions to alleviate FT and related problems.

KW - Financial Toxicity

KW - Cancer

KW - United Kingdom (UK)

KW - Health economics

U2 - 10.1093/pubmed/fdad143

DO - 10.1093/pubmed/fdad143

M3 - Article

C2 - 37541834

SN - 1741-3850

VL - 45

SP - e702-e713

JO - Journal of Public Health

JF - Journal of Public Health

IS - 4

ER -

Financial toxicity among cancer patients, survivors and their families in the United Kingdom: a scoping review

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Projects

R2026CPH: Understanding causes & impacts of financial toxicity among cancer patients, survivors, and their family in the United Kingdom (GIFT)

Prizes

Wellcome Early-Career Award

Research output

Financial toxicity amongst cancer patients and survivors: a comparative study of the United Kingdom and United States

Cite this